BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Vaccine News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
Drug Giant Merck & Co. Buys Rights To NewLink Genetics Ebola Vaccine rVSV-EBOV     11/24/2014
GlaxoSmithKline Shareholders To Vote On Novartis AG Deal On Dec. 18     11/24/2014
Universal Flu Vaccine Co BiondVax Pharmaceuticals Mulls NY IPO     11/24/2014
Merck & Co., NewLink Genetics In Secret Talks On Producing Ebola Vaccine     11/21/2014
U.S. FDA Grants Fast Track Designation To Novavax, Inc.' RSV F-Protein Nanoparticle Vaccine For Protection Of Infants Via Maternal Immunization     11/20/2014
Best Value In Biotech? Actavis, Says UBS     11/17/2014
EU, Drugmakers Pledge $350 Million For Research On Ebola Vaccines, Tests     11/6/2014
Canadian Government Commits $30.5 Million To Ebola     11/4/2014
Bill & Melinda Gates Foundation Announce $156 Million Grant For Developing Malaria Vaccines     11/3/2014
Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant     10/31/2014
Pfizer Wins FDA Accelerated Approval For Meningitis Vaccine     10/30/2014
ImevaX Secures EUR 7.5 Million In Series A Financing To Develop Highly Specific Vaccine Against Helicobacter Pylori Infections     10/28/2014
Novartis AG Sells Flu Vaccine Business For $275 Million To CSL Limited     10/28/2014
New Role Created At GlaxoSmithKline's Vaccines Unit     10/23/2014
NIH Begins Early Human Clinical Trial Of VSV Ebola Vaccine     10/23/2014
 Featured Stories
Ebola Vaccine Running Into Patent Cover In Canada?     11/21/2014
Do-It-Yourself Flu Vaccine? Study Shows It Works, U.S. Military Vaccine Agency Reveals     10/9/2014
Intestinal Bacteria May Boost Flu Shot's Effects, Emory University Study     9/18/2014
Robert Kennedy's Dangerous Anti-Vaccine Activism     7/22/2014
A Vaccination To Prevent Heart Attacks? Harvard Stem Cell Institute Study     6/11/2014
Vaccine Combo Doubles Seizure Risk In Babies, University of Calgary Study     6/10/2014
Zero Link Between Autism And Vaccines, Vaccine Reveals     5/20/2014
Body Odor Changes Following Vaccination, Monell Chemical Senses Center And United States Department Of Agriculture (USDA) Study     4/3/2014
Proteins May Pave Way to Cow Vaccine, University of Florida Study     7/19/2011
Discovery of Natural Antibody Brings a Universal Flu Vaccine a Step Closer, The Scripps Research Institute Study     7/11/2011
Leeds University Scientists Develop New Approach For Cancer Vaccine     6/21/2011
Drugmakers Including Novartis AG Gear Up to Copy Biotech Drugs in U.S.     5/12/2011
Nasal Spray Vaccine Could Spell the End of the Flu Jab, Albany Medical College Experts Say     4/12/2011
Vaccine Could Cure Cat Allergies, McMaster University Study Suggests     4/6/2011
Promising Target for AIDS Vaccine, Dana-Farber Cancer Institute Study Reveals     4/1/2011
 More News
Themis Bioscience’s Vaccine Against Chikungunya Successful In Phase 1     11/20/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine     11/20/2014
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine     11/19/2014
MYMETICS Corporation Announces New Collaboration To Advance The Development Of An Innovative Malaria Vaccine Candidate     11/18/2014
TapImmune Inc. (TPIV) Announces Phase 2 Clinical Trials Collaboration With VGTI Florida To Advance Breast And Ovarian Cancer Vaccines     11/18/2014
Canadian Institutes Of Health Research Release: Canada Begins Ebola Vaccine Trial     11/14/2014
ABIVAX Signs Agreement With The Finlay Institute To Commercialise Meningococcal And Typhoid Vaccines In Asia And Latin America     11/12/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older     10/30/2014
FDA Grants Fast Track Designation To Novavax, Inc. (NVAX)' H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M™     10/30/2014
The National Meningitis Association Applauds FDA Approval Of First Serogroup B Meningococcal Disease Vaccine     10/30/2014
Contract Research Organization WCCT Global Announces Involvement In H1N1 Oral Vaccine Development     10/28/2014
BioNet Appoints New COO And Accelerates The Development Of New Recombinant Pertussis Vaccine     10/28/2014
Novavax, Inc. (NVAX) Presents RSV F Protein Nanoparticle Vaccine Clinical Data At The 8th Vaccine & ISV Congress In Philadelphia On Sunday, October 26     10/27/2014
FDA Accepts For Review A Biologics License Application For Merck & Co. (MRK) And Sanofi Pasteur (SASY.PA)’s Investigational Pediatric Hexavalent Vaccine     10/20/2014
Novavax, Inc. (NVAX) Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies     10/15/2014